Chandan Healthcare Limited, established on September 03, 2003, specializes in operating state-of-the-art laboratories that offer comprehensive pathological investigations. the Company run a diagnostic network in North India with pathology and radiology testing services. Their services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs.

the Company commenced business by starting its first diagnostic centre in Indra Nagar, Lucknow in 2003. Later, it started the diagnostic centre in Dehradun in 2013. It has established a chain of Retail Pharmacies in Uttar Pradesh, Uttarakhand, and Delhi, along with wholesale distribution to our retail outlets and hospitals. Operating in Lucknow, Chandan Hospital Limited is a 300-bed tertiary care Multi-Super-specialty Hospital that has quickly gained recognition as one of the leading hospitals in the region since its opening on October 1st, 2018.

As of August 31, 2024, the Company has 1 flagship laboratory, 7 central laboratories, 26 satellite centres, more than 300 collection centres and located across India, with facilities in more than 15 cities and towns across Uttar Pradesh and more than 10 cities and towns in Uttarakhand. Out of various laboratories, 8 are National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited while three of the diagnostic centres have National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation.

Apart from these, the Company provide nearly 1118 tests across different specialties. These test menu includes 169 routine pathology tests, covering basic biochemistry and hematology, as well as 713 specialized pathology tests, such as immohistopathology, and molecular pathology, and 236 radiology tests, including basic x-rays, ultrasonography (USG), computed tomography (CT), magnetic resonance imaging (MRI), and specialized CT scans. Radiology facilities have 11 CT scanners and 4 MRI machines. Committed to accuracy and reliability, the Company supports healthcare professionals and patients by delivering essential diagnostic services.

the Company is planning an IPO aggregating upto 68,99,936 Equity Shares of Face Value of Rs 10 each comprising a Fresh Issue of 46,00,000 Equity Shares and 22,99,936 Equity Shares through Offer for Sale.